🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison of 2 doses of empagliflozin vs placebo in patients already using...
Status
Completed
Location
AMCR Institute, Inc.
Start Date
2015-06-30
Trial ID
NCT02414958
Treatments Being Tested
This study aims to understand the heart and blood sugar health benefits of ...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2025-07-03
Trial ID
NCT06609356
Treatments Being Tested
A. Four groups of patients with type 2 diabetes mellitus with high or very ...
Status
Recruiting
Location
"Attikon" University General Hospital
Start Date
2017-11-03
Trial ID
NCT03878706
The aim of this study is to investigate the efficacy and safety of two dose...
Status
Completed
Location
1276.10.11036 Boehringer Ingelheim Investigational Site
Start Date
2012-10
Trial ID
NCT01649297
Investigation of food effect on the bioavailability of a 25 mg empagliflozi...
Status
Completed
Location
1245.79.1 Boehringer Ingelheim Investigational Site
Start Date
2011-10
Trial ID
NCT01451775
Treatments Being Tested
Idiopathic immunoglobulin A nephropathy (IgAN) is the most common biopsy-pr...
Status
Recruiting
Location
francesco paolo Schena
Start Date
2023-05-01
Trial ID
NCT04662723
Treatments Being Tested
This is a randomized, open-label, single dose, crossover, phase 1 trial to ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-07-04
Trial ID
NCT06492655
Treatments Being Tested
This study will investigate the efficacy and safety of BI 10773 in type 2 d...
Status
Completed
Location
1245.19.10056 Boehringer Ingelheim Investigational Site
Start Date
2010-09
Trial ID
NCT01210001
This trial is designed to investigate the efficacy and safety of empagliflo...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-07-25
Trial ID
NCT02182830
Treatments Being Tested
The association of novel inflammatory biomarkers with cardiovascular diseas...
Status
Completed
Location
Tanta University Hospital
Start Date
2023-03-01
Trial ID
NCT05911724